Industry News
New, Three-Year Field Trial Results on the Efficacy of XylPhi-PD™ for Pierce’s Disease Prevention and Control
Palo Alto, CA – December 9, 2021– A&P Inphatec, a specialist developer of bacteriophages, announces the release of…
Read Article